Stay updated on Dauno/Cytarabine ± Uproleselan in AML Clinical Trial
Sign up to get notified when there's something new on the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page.

Latest updates to the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision history updated: added version v3.5.0 and removed version v3.4.3.SummaryDifference0.0%

- Check25 days agoChange DetectedThe Record History now includes a new revision entry v3.4.3 and removes v3.4.2 from the history.SummaryDifference0.0%

- Check54 days agoChange DetectedAdded Revision: v3.4.2 to the history and removed the government-funding notices along with the older Revision: v3.4.1.SummaryDifference0.1%

- Check61 days agoChange DetectedAdded a government-funding notice and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check68 days agoChange DetectedA new revision entry on 2026-01-21 adds the 'Results Posted' item and introduces color-coded diffs (green for additions, red for deletions) across key sections, along with a 'Show glossary' option. The 2025-10-29 'Results Submitted' entry appears as a deletion in the history.SummaryDifference0.4%

- Check82 days agoChange DetectedRevision: v3.3.4 was added to the page history, replacing the previous v3.3.3 entry.SummaryDifference0.0%

Stay in the know with updates to Dauno/Cytarabine ± Uproleselan in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page.